nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—SV2A—bronchus—chronic obstructive pulmonary disease	0.0251	0.257	CbGeAlD
Levetiracetam—CACNA1B—respiratory system—chronic obstructive pulmonary disease	0.0211	0.216	CbGeAlD
Levetiracetam—CACNA1B—connective tissue—chronic obstructive pulmonary disease	0.0185	0.19	CbGeAlD
Levetiracetam—SV2A—lung—chronic obstructive pulmonary disease	0.0162	0.166	CbGeAlD
Levetiracetam—CACNA1B—lung—chronic obstructive pulmonary disease	0.0112	0.115	CbGeAlD
Levetiracetam—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00245	0.0251	CbGeAlD
Levetiracetam—ABCB1—trachea—chronic obstructive pulmonary disease	0.00181	0.0186	CbGeAlD
Levetiracetam—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00164	CcSEcCtD
Levetiracetam—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00164	CcSEcCtD
Levetiracetam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.00162	CcSEcCtD
Levetiracetam—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00161	CcSEcCtD
Levetiracetam—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.0016	CcSEcCtD
Levetiracetam—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.0016	CcSEcCtD
Levetiracetam—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.0016	CcSEcCtD
Levetiracetam—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00159	CcSEcCtD
Levetiracetam—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00159	CcSEcCtD
Levetiracetam—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00158	CcSEcCtD
Levetiracetam—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00157	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.00157	CcSEcCtD
Levetiracetam—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00156	CcSEcCtD
Levetiracetam—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00156	CcSEcCtD
Levetiracetam—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00156	CcSEcCtD
Levetiracetam—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00156	CcSEcCtD
Levetiracetam—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00155	CcSEcCtD
Levetiracetam—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00155	CcSEcCtD
Levetiracetam—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00139	0.00154	CcSEcCtD
Levetiracetam—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00153	CcSEcCtD
Levetiracetam—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00151	CcSEcCtD
Levetiracetam—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.00136	0.0015	CcSEcCtD
Levetiracetam—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.0015	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00134	0.00149	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00148	CcSEcCtD
Levetiracetam—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00148	CcSEcCtD
Levetiracetam—Cough—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00148	CcSEcCtD
Levetiracetam—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00147	CcSEcCtD
Levetiracetam—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00147	CcSEcCtD
Levetiracetam—Cough—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00145	CcSEcCtD
Levetiracetam—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.00131	0.00145	CcSEcCtD
Levetiracetam—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00145	CcSEcCtD
Levetiracetam—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00145	CcSEcCtD
Levetiracetam—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00145	CcSEcCtD
Levetiracetam—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00145	CcSEcCtD
Levetiracetam—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00145	CcSEcCtD
Levetiracetam—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00145	CcSEcCtD
Levetiracetam—ABCB1—lung—chronic obstructive pulmonary disease	0.0013	0.0133	CbGeAlD
Levetiracetam—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00144	CcSEcCtD
Levetiracetam—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00144	CcSEcCtD
Levetiracetam—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00144	CcSEcCtD
Levetiracetam—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00144	CcSEcCtD
Levetiracetam—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00144	CcSEcCtD
Levetiracetam—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00144	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00144	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00144	CcSEcCtD
Levetiracetam—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00142	CcSEcCtD
Levetiracetam—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00142	CcSEcCtD
Levetiracetam—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00127	0.00141	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00127	0.00141	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.0014	CcSEcCtD
Levetiracetam—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.0014	CcSEcCtD
Levetiracetam—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00138	CcSEcCtD
Levetiracetam—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00138	CcSEcCtD
Levetiracetam—Infection—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00138	CcSEcCtD
Levetiracetam—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00137	CcSEcCtD
Levetiracetam—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00137	CcSEcCtD
Levetiracetam—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00137	CcSEcCtD
Levetiracetam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00136	CcSEcCtD
Levetiracetam—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00136	CcSEcCtD
Levetiracetam—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00136	CcSEcCtD
Levetiracetam—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00136	CcSEcCtD
Levetiracetam—Infection—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00135	CcSEcCtD
Levetiracetam—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00122	0.00135	CcSEcCtD
Levetiracetam—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00135	CcSEcCtD
Levetiracetam—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00135	CcSEcCtD
Levetiracetam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00134	CcSEcCtD
Levetiracetam—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00133	CcSEcCtD
Levetiracetam—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00133	CcSEcCtD
Levetiracetam—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00133	CcSEcCtD
Levetiracetam—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00132	CcSEcCtD
Levetiracetam—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00131	CcSEcCtD
Levetiracetam—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.0013	CcSEcCtD
Levetiracetam—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00129	CcSEcCtD
Levetiracetam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00129	CcSEcCtD
Levetiracetam—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00128	CcSEcCtD
Levetiracetam—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00127	CcSEcCtD
Levetiracetam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00127	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00126	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00126	CcSEcCtD
Levetiracetam—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00125	CcSEcCtD
Levetiracetam—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00125	CcSEcCtD
Levetiracetam—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00125	CcSEcCtD
Levetiracetam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.00125	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00124	CcSEcCtD
Levetiracetam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00123	CcSEcCtD
Levetiracetam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00123	CcSEcCtD
Levetiracetam—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00123	CcSEcCtD
Levetiracetam—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00122	CcSEcCtD
Levetiracetam—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00122	CcSEcCtD
Levetiracetam—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00122	CcSEcCtD
Levetiracetam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00122	CcSEcCtD
Levetiracetam—Injury—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00121	CcSEcCtD
Levetiracetam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00121	CcSEcCtD
Levetiracetam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.0012	CcSEcCtD
Levetiracetam—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.0012	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.0012	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00108	0.0012	CcSEcCtD
Levetiracetam—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00108	0.0012	CcSEcCtD
Levetiracetam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.0012	CcSEcCtD
Levetiracetam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00108	0.0012	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00119	CcSEcCtD
Levetiracetam—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00119	CcSEcCtD
Levetiracetam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00119	CcSEcCtD
Levetiracetam—Pain—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00119	CcSEcCtD
Levetiracetam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00119	CcSEcCtD
Levetiracetam—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00118	CcSEcCtD
Levetiracetam—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00118	CcSEcCtD
Levetiracetam—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00118	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00117	CcSEcCtD
Levetiracetam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00117	CcSEcCtD
Levetiracetam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00116	CcSEcCtD
Levetiracetam—Pain—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00116	CcSEcCtD
Levetiracetam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00116	CcSEcCtD
Levetiracetam—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00115	CcSEcCtD
Levetiracetam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00115	CcSEcCtD
Levetiracetam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00115	CcSEcCtD
Levetiracetam—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00114	CcSEcCtD
Levetiracetam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00114	CcSEcCtD
Levetiracetam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00114	CcSEcCtD
Levetiracetam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.00114	CcSEcCtD
Levetiracetam—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00114	CcSEcCtD
Levetiracetam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00114	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00113	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00113	CcSEcCtD
Levetiracetam—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00113	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00113	CcSEcCtD
Levetiracetam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00113	CcSEcCtD
Levetiracetam—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00112	CcSEcCtD
Levetiracetam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00112	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.001	0.00111	CcSEcCtD
Levetiracetam—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000989	0.0011	CcSEcCtD
Levetiracetam—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000989	0.0011	CcSEcCtD
Levetiracetam—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000989	0.0011	CcSEcCtD
Levetiracetam—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000989	0.0011	CcSEcCtD
Levetiracetam—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000986	0.00109	CcSEcCtD
Levetiracetam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000986	0.00109	CcSEcCtD
Levetiracetam—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000979	0.00108	CcSEcCtD
Levetiracetam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000978	0.00108	CcSEcCtD
Levetiracetam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000977	0.00108	CcSEcCtD
Levetiracetam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000977	0.00108	CcSEcCtD
Levetiracetam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000974	0.00108	CcSEcCtD
Levetiracetam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000971	0.00108	CcSEcCtD
Levetiracetam—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000969	0.00107	CcSEcCtD
Levetiracetam—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000969	0.00107	CcSEcCtD
Levetiracetam—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000967	0.00107	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000966	0.00107	CcSEcCtD
Levetiracetam—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000956	0.00106	CcSEcCtD
Levetiracetam—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000949	0.00105	CcSEcCtD
Levetiracetam—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000934	0.00104	CcSEcCtD
Levetiracetam—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000934	0.00104	CcSEcCtD
Levetiracetam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000922	0.00102	CcSEcCtD
Levetiracetam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000922	0.00102	CcSEcCtD
Levetiracetam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000921	0.00102	CcSEcCtD
Levetiracetam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000903	0.001	CcSEcCtD
Levetiracetam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000898	0.000995	CcSEcCtD
Levetiracetam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000898	0.000995	CcSEcCtD
Levetiracetam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000885	0.000981	CcSEcCtD
Levetiracetam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000885	0.000981	CcSEcCtD
Levetiracetam—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000884	0.000979	CcSEcCtD
Levetiracetam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000879	0.000974	CcSEcCtD
Levetiracetam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000871	0.000965	CcSEcCtD
Levetiracetam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000867	0.000961	CcSEcCtD
Levetiracetam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000856	0.000949	CcSEcCtD
Levetiracetam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000856	0.000949	CcSEcCtD
Levetiracetam—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000849	0.000941	CcSEcCtD
Levetiracetam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000848	0.000939	CcSEcCtD
Levetiracetam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000839	0.000929	CcSEcCtD
Levetiracetam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.000926	CcSEcCtD
Levetiracetam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000827	0.000917	CcSEcCtD
Levetiracetam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000827	0.000917	CcSEcCtD
Levetiracetam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00081	0.000898	CcSEcCtD
Levetiracetam—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00081	0.000897	CcSEcCtD
Levetiracetam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000808	0.000896	CcSEcCtD
Levetiracetam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000796	0.000882	CcSEcCtD
Levetiracetam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000796	0.000882	CcSEcCtD
Levetiracetam—Rash—Formoterol—chronic obstructive pulmonary disease	0.000789	0.000874	CcSEcCtD
Levetiracetam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000789	0.000874	CcSEcCtD
Levetiracetam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000788	0.000873	CcSEcCtD
Levetiracetam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000788	0.000873	CcSEcCtD
Levetiracetam—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000788	0.000873	CcSEcCtD
Levetiracetam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000784	0.000869	CcSEcCtD
Levetiracetam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000784	0.000869	CcSEcCtD
Levetiracetam—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000783	0.000868	CcSEcCtD
Levetiracetam—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000783	0.000867	CcSEcCtD
Levetiracetam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000781	0.000866	CcSEcCtD
Levetiracetam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000779	0.000864	CcSEcCtD
Levetiracetam—Rash—Montelukast—chronic obstructive pulmonary disease	0.000773	0.000856	CcSEcCtD
Levetiracetam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000772	0.000856	CcSEcCtD
Levetiracetam—Depression—Prednisone—chronic obstructive pulmonary disease	0.00077	0.000853	CcSEcCtD
Levetiracetam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000768	0.000851	CcSEcCtD
Levetiracetam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000751	0.000832	CcSEcCtD
Levetiracetam—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000746	0.000827	CcSEcCtD
Levetiracetam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.000826	CcSEcCtD
Levetiracetam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000744	0.000825	CcSEcCtD
Levetiracetam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000743	0.000824	CcSEcCtD
Levetiracetam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000743	0.000824	CcSEcCtD
Levetiracetam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00074	0.00082	CcSEcCtD
Levetiracetam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000728	0.000807	CcSEcCtD
Levetiracetam—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000719	0.000797	CcSEcCtD
Levetiracetam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.000778	CcSEcCtD
Levetiracetam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00069	0.000764	CcSEcCtD
Levetiracetam—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000681	0.000755	CcSEcCtD
Levetiracetam—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000648	0.000718	CcSEcCtD
Levetiracetam—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000626	0.000694	CcSEcCtD
Levetiracetam—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000613	0.000679	CcSEcCtD
Levetiracetam—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000612	0.000679	CcSEcCtD
Levetiracetam—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000609	0.000674	CcSEcCtD
Levetiracetam—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000607	0.000673	CcSEcCtD
Levetiracetam—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000603	0.000669	CcSEcCtD
Levetiracetam—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00058	0.000642	CcSEcCtD
Levetiracetam—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000569	0.00063	CcSEcCtD
Levetiracetam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000558	0.000619	CcSEcCtD
Levetiracetam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000554	0.000614	CcSEcCtD
Levetiracetam—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000542	0.000601	CcSEcCtD
Levetiracetam—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000523	0.000579	CcSEcCtD
Levetiracetam—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000514	0.000569	CcSEcCtD
Levetiracetam—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000514	0.000569	CcSEcCtD
Levetiracetam—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000512	0.000567	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00051	0.000565	CcSEcCtD
Levetiracetam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000499	0.000553	CcSEcCtD
Levetiracetam—Infection—Prednisone—chronic obstructive pulmonary disease	0.000489	0.000542	CcSEcCtD
Levetiracetam—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000483	0.000535	CcSEcCtD
Levetiracetam—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000478	0.00053	CcSEcCtD
Levetiracetam—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000469	0.00052	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000449	0.000497	CcSEcCtD
Levetiracetam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000448	0.000497	CcSEcCtD
Levetiracetam—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000445	0.000494	CcSEcCtD
Levetiracetam—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000442	0.00049	CcSEcCtD
Levetiracetam—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000433	0.00048	CcSEcCtD
Levetiracetam—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000428	0.000474	CcSEcCtD
Levetiracetam—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.000473	CcSEcCtD
Levetiracetam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.000473	CcSEcCtD
Levetiracetam—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000425	0.00047	CcSEcCtD
Levetiracetam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000425	0.00047	CcSEcCtD
Levetiracetam—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000467	CcSEcCtD
Levetiracetam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000406	0.00045	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000403	0.000446	CcSEcCtD
Levetiracetam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000403	0.000446	CcSEcCtD
Levetiracetam—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000389	0.000431	CcSEcCtD
Levetiracetam—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000389	0.000431	CcSEcCtD
Levetiracetam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000402	CcSEcCtD
Levetiracetam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000353	0.000392	CcSEcCtD
Levetiracetam—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000348	0.000386	CcSEcCtD
Levetiracetam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000373	CcSEcCtD
Levetiracetam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000361	CcSEcCtD
Levetiracetam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000313	0.000347	CcSEcCtD
Levetiracetam—Rash—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000344	CcSEcCtD
Levetiracetam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000344	CcSEcCtD
Levetiracetam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000308	0.000342	CcSEcCtD
Levetiracetam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000324	CcSEcCtD
